Beyond Air, Inc. (XAIR)
XAIR Stock Price Chart
Explore Beyond Air, Inc. interactive price chart. Choose custom timeframes to analyze XAIR price movements and trends.
XAIR Company Profile
Discover essential business fundamentals and corporate details for Beyond Air, Inc. (XAIR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Jun 2018
Employees
107.00
Website
https://www.beyondair.netCEO
Steven Adam Lisi
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
XAIR Financial Timeline
Browse a chronological timeline of Beyond Air, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 10 Nov 2025
EPS estimate is -$1.24.
Earnings released on 12 Aug 2025
EPS came in at -$1.53 falling short of the estimated -$1.50 by -2.00%, while revenue for the quarter reached $1.76M , missing expectations by -29.31%.
Stock split effective on 14 Jul 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Jun 2025
EPS came in at -$1.80 surpassing the estimated -$2.80 by +35.71%, while revenue for the quarter reached $1.15M , missing expectations by -44.15%.
Earnings released on 10 Feb 2025
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $1.07M , missing expectations by -22.79%.
Earnings released on 11 Nov 2024
EPS came in at -$0.28 surpassing the estimated -$0.30 by +6.67%, while revenue for the quarter reached $798.00K , missing expectations by -23.27%.
Earnings released on 6 Aug 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%, while revenue for the quarter reached $683.00K , missing expectations by -51.56%.
Earnings released on 24 Jun 2024
EPS came in at -$0.36 surpassing the estimated -$0.47 by +23.40%, while revenue for the quarter reached $470.00K , missing expectations by -37.33%.
Earnings released on 12 Feb 2024
EPS came in at -$0.50 surpassing the estimated -$0.61 by +18.03%, while revenue for the quarter reached $391.00K , missing expectations by -13.11%.
Earnings released on 13 Nov 2023
EPS came in at -$0.51 falling short of the estimated -$0.47 by -8.51%, while revenue for the quarter reached $239.00K , missing expectations by -50.21%.
Earnings released on 10 Aug 2023
EPS came in at -$0.45 surpassing the estimated -$0.46 by +2.17%, while revenue for the quarter reached $59.00K , missing expectations by -82.65%.
Earnings released on 22 Jun 2023
EPS came in at -$0.67 falling short of the estimated -$0.44 by -52.27%.
Earnings released on 9 Feb 2023
EPS came in at -$0.43 falling short of the estimated -$0.42 by -2.38%.
Earnings released on 8 Nov 2022
EPS came in at -$0.40 falling short of the estimated -$0.36 by -11.11%.
Earnings released on 11 Aug 2022
EPS came in at -$0.37 falling short of the estimated -$0.28 by -32.14%.
Earnings released on 28 Jun 2022
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%.
Earnings released on 10 Feb 2022
EPS came in at -$0.29 falling short of the estimated -$0.25 by -16.00%.
Earnings released on 11 Nov 2021
EPS came in at -$0.36 falling short of the estimated -$0.25 by -44.00%.
Earnings released on 10 Aug 2021
EPS came in at -$0.31 falling short of the estimated -$0.19 by -63.16%.
Earnings released on 10 Jun 2021
EPS came in at -$0.24 surpassing the estimated -$0.33 by +27.27%, while revenue for the quarter reached $145.63K .
Earnings released on 9 Feb 2021
EPS came in at -$0.33 falling short of the estimated -$0.31 by -6.45%, while revenue for the quarter reached $149.00K , beating expectations by +7.04%.
Earnings released on 11 Nov 2020
EPS came in at -$0.30 surpassing the estimated -$0.31 by +3.23%, while revenue for the quarter reached $350.00K , beating expectations by +0.11%.
XAIR Stock Performance
Access detailed XAIR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.